On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Today’s new cars pack in more high-tech electronic features than ever before, including in the key fob. The device has gone far beyond simply locking or unlocking doors, remotely starting a car, or ...

Heuristics simplify decision-making by using mental shortcuts. Understand their pros, cons, and examples in finance and ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...